Debt-to-equity of PLUS THERAPEUTICS, INC. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PLUS THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • PLUS THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was -295%, a 3.3% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

PLUS THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -295% -9% -3.3% 30 Sep 2025
Q2 2025 -204% +267% +57% 30 Jun 2025
Q1 2025 -181% +4856% +96% 31 Mar 2025
Q4 2024 -215% -939% -130% 31 Dec 2024
Q3 2024 -285% -650% -178% 30 Sep 2024
Q2 2024 -471% -702% -304% 30 Jun 2024
Q1 2024 -5037% -5215% -2934% 31 Mar 2024
Q4 2023 724% +604% +504% 31 Dec 2023
Q3 2023 365% +270% +284% 30 Sep 2023
Q2 2023 231% +146% +171% 30 Jun 2023
Q1 2023 178% +101% +132% 31 Mar 2023
Q4 2022 120% +37% +45% 31 Dec 2022
Q3 2022 95% +1% +1.5% 30 Sep 2022
Q2 2022 85% -47% -35% 30 Jun 2022
Q1 2022 76% -127% -62% 31 Mar 2022
Q4 2021 83% -466% -85% 31 Dec 2021
Q3 2021 94% -780% -89% 30 Sep 2021
Q2 2021 132% -1549% -92% 30 Jun 2021
Q1 2021 203% +1921% 31 Mar 2021
Q4 2020 549% +8151% 31 Dec 2020
Q3 2020 873% -1832% -68% 30 Sep 2020
Q2 2020 1681% +853% +103% 30 Jun 2020
Q1 2020 -1718% -2102% -546% 31 Mar 2020
Q4 2019 -7602% -7904% -2618% 31 Dec 2019
Q3 2019 2705% +2476% +1082% 30 Sep 2019
Q2 2019 828% +613% +285% 30 Jun 2019
Q1 2019 385% +196% +103% 31 Mar 2019
Q4 2018 302% +97% +47% 31 Dec 2018
Q3 2018 229% -1% -0.34% 30 Sep 2018
Q2 2018 215% +6% +3% 30 Jun 2018
Q1 2018 189% +6% +3% 31 Mar 2018
Q4 2017 205% +18% +9.4% 31 Dec 2017
Q3 2017 230% +43% +23% 30 Sep 2017
Q2 2017 209% -47% -19% 30 Jun 2017
Q1 2017 184% -303% -62% 31 Mar 2017
Q4 2016 188% +4678% 31 Dec 2016
Q3 2016 187% +1048% 30 Sep 2016
Q2 2016 257% +873% 30 Jun 2016
Q1 2016 487% +1059% 31 Mar 2016
Q4 2015 -4490% -1637% -57% 31 Dec 2015
Q3 2015 -861% -5189% -120% 30 Sep 2015
Q2 2015 -617% -4895% -114% 30 Jun 2015
Q1 2015 -572% -4808% -114% 31 Mar 2015
Q4 2014 -2854% -6961% -169% 31 Dec 2014
Q3 2014 4328% +2230% +106% 30 Sep 2014
Q2 2014 4278% -37540% -90% 30 Jun 2014
Q1 2014 4235% +45646% 31 Mar 2014
Q4 2013 4107% +207% +5.3% 31 Dec 2013
Q3 2013 2098% -77% -3.5% 30 Sep 2013
Q2 2013 41818% +41246% +7210% 30 Jun 2013
Q1 2013 -41410% -41838% -9789% 31 Mar 2013
Q4 2012 3901% 31 Dec 2012
Q3 2012 2175% 30 Sep 2012
Q2 2012 572% 30 Jun 2012
Q1 2012 427% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.